BeyondSpring (BYSI) Minority Interest (2015 - 2026)
BeyondSpring (BYSI) posted Minority Interest of $4.1 million for Q1 2026, down 49.42% sequentially from $8.2 million in Q4 2025, and down 73.58% YoY from $15.6 million in Q1 2025.
BeyondSpring (BYSI) Minority Interest (2015 - 2026) Analysis & Trends
BeyondSpring has reported Minority Interest for 12 years, with the latest figure at $4.1 million in Q1 2026.
- Quarterly Minority Interest fell 73.58% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (down 73.58% YoY) and the FY2025 annual result came in at $8.2 million, down 56.11% from the prior year.
- Minority Interest eased to $4.1 million in Q1 2026 per BYSI's latest filing, from $8.2 million in the prior quarter.
- Over five years, Minority Interest peaked at $18.6 million in Q4 2024 and troughed at $4.1 million in Q1 2026.
- A 5-year average of $11.7 million and a median of $11.9 million in 2023 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2022 and 2026: Minority Interest surged 103.04% in 2022, then sank 73.58% in 2026.
- Over 5 years, Minority Interest stood at $11.1 million in 2022, then gained by 7.22% to $11.9 million in 2023, then jumped by 56.77% to $18.6 million in 2024, then plunged by 56.11% to $8.2 million in 2025, then slumped by 49.42% to $4.1 million in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered $4.1 million, $8.2 million, and $12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BeyondSpring | 30.22 Mn | 30.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -459,000.00 |
| Mar 31, 2026 | 4.13 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Sep 30, 2025 | 11.97 Mn |
| Jun 30, 2025 | 12.67 Mn |
| Mar 31, 2025 | 15.64 Mn |
| Dec 31, 2024 | 18.62 Mn |
| Jun 30, 2024 | 12.27 Mn |
| Dec 31, 2023 | 11.87 Mn |
| Jun 30, 2023 | 11.47 Mn |
| Dec 31, 2022 | 11.07 Mn |
| Jun 30, 2022 | 10.67 Mn |
| Dec 31, 2021 | 5.45 Mn |
| Sep 30, 2021 | 5.35 Mn |
| Jun 30, 2021 | 5.26 Mn |
| Mar 31, 2021 | 5.20 Mn |
| Dec 31, 2020 | 5.20 Mn |
| Sep 30, 2020 | -1.12 Mn |
| Jun 30, 2020 | -514,000.00 |
| Mar 31, 2020 | 304,000.00 |